Thatchawan Thanasupawat

INSL5 is a novel marker for human enteroendocrine cells of the large intestine and neuroendocrine tumours.

C1q-tumour necrosis factor-related protein 8 (CTRP8) is a novel interaction partner of relaxin receptor RXFP1 in human brain cancer cells.

Mechanisms of therapeutic resistance in cancer (stem) cells with emphasis on thyroid cancer cells.

Platinum (IV) coiled coil nanotubes selectively kill human glioblastoma cells.

RXFP1 is Targeted by Complement C1q Tumor Necrosis Factor-Related Factor 8 in Brain Cancer.

PDK2-mediated alternative splicing switches Bnip3 from cell death to cell survival.

Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.

Dovitinib enhances temozolomide efficacy in glioblastoma cells.

C1q/TNF-related peptide 8 (CTRP8) promotes temozolomide resistance in human glioblastoma.

HMGA2 as a functional antagonist of PARP1 inhibitors in tumor cells.

Emerging roles for the relaxin/RXFP1 system in cancer therapy.

Novel CTRP8-RXFP1-JAK3-STAT3 axis promotes Cdc42-dependent actin remodeling for enhanced filopodia formation and motility in human glioblastoma cells.

Slow Off-Rate Modified Aptamer (SOMAmer) Proteomic Analysis of Patient-Derived Malignant Glioma Identifies Distinct Cellular Proteomes.

Ubiquitin Proteasome Gene Signatures in Ependymoma Molecular Subtypes.

Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling.

Human C1q Tumor Necrosis Factor 8 (CTRP8) defines a novel tryptase+ mast cell subpopulation in the prostate cancer microenvironment.

Characterization of HMGA2 variants expands the spectrum of Silver-Russell syndrome.

Overcoming brain-derived therapeutic resistance in HER2+ breast cancer brain metastasis.

C1QTNF Related protein 8 (CTRP8) is a marker of myeloid derived innate immune cell populations in the human breast cancer microenvironment.